Axsome Therapeutics, Inc. (AXSM)
146.46
+1.24
(+0.85%)
USD |
NASDAQ |
Dec 10, 11:14
Axsome Therapeutics Profit Margin (Quarterly): -27.62% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Fortress Biotech, Inc. | 50.07% |
| TG Therapeutics, Inc. | -- |
| Karyopharm Therapeutics, Inc. | -75.21% |
| Viking Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -328.0% |
| Return on Assets | -37.81% |
| Return on Invested Capital | -82.07% |
| Gross Profit Margin (Quarterly) | 91.62% |
| Operating Margin (Quarterly) | -19.25% |
| Return on Net Operating Assets | -88.81% |